Market Research Reports and Industry Reports

Bioverativ Inc (BIVV) - Financial and Strategic SWOT Analysis Review

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Bioverativ Inc (BIVV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bioverativ Inc (Bioverativ) is a biotechnology company that discovers, develops, and markets therapeutics for the treatment of hemophilia, and rare blood disorders. Its product portfolio includes Eloctate, which comprises recombinant antihemophilic factor engineered using Fc fusion technology for the treatment of hemophilia A; and Alprolix, which comprises recombinant coagulation factor IX engineered using Fc fusion technology for the treatment of hemophilia B. The companys pipeline encompasses investigational candidates for the treatment of cold agglutinin disease, hemophilia A, beta thalassemia sickle cell disease, hemophilia B, and Sickle cell disease. Bioverativ sells its products in the US, the European Union (EU), New Zealand, Canada, Australia, Japan, Switzerland, Iceland, Liechtenstein, and Norway. The company manufactures its products at Biogens Research facility in North Carolina, the US. Bioverativ is headquartered in Waltham, Massachusetts, the US.

Bioverativ Inc Key Recent Developments

Aug 02,2017: Bioverativ Reports Second Quarter 2017 Performance
Jul 06,2017: New Data to be Presented at ISTH Underscore Bioverativs Commitment to Advance Hemophilia Care
May 15,2017: Bioverativ Appoints Geno J. Germano to Companys Board of Directors
May 03,2017: Bioverativ Reports First Quarter 2017 Results
Apr 10,2017: Bioverativ Appoints Tim Harris Executive Vice President, Research and Development

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Bioverativ Inc - Key Facts 5
Bioverativ Inc - Key Employees 6
Bioverativ Inc - Key Employee Biographies 7
Bioverativ Inc - Major Products and Services 8
Bioverativ Inc - Locations And Subsidiaries 9
Head Office 9
Other Locations & Subsidiaries 9
Section 2 Company Analysis 10
Bioverativ Inc - Business Description 10
Bioverativ Inc - SWOT Analysis 11
SWOT Analysis - Overview 11
Bioverativ Inc - Strengths 11
Bioverativ Inc - Weaknesses 12
Bioverativ Inc - Opportunities 13
Bioverativ Inc - Threats 14
Bioverativ Inc - Key Competitors 15
Section 3 Company Financial Ratios 16
Financial Ratios - Capital Market Ratios 16
Financial Ratios - Annual Ratios 17
Performance Chart 19
Financial Performance 19
Financial Ratios - Interim Ratios 20
Financial Ratios - Ratio Charts 21
Section 4 Companys Lifesciences Financial Deals and Alliances 22
Bioverativ Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 22
Bioverativ Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 23
Bioverativ Inc, Recent Deals Summary 24
Section 5 Companys Recent Developments 25
Aug 02, 2017: Bioverativ Reports Second Quarter 2017 Performance 25
Jul 06, 2017: New Data to be Presented at ISTH Underscore Bioverativs Commitment to Advance Hemophilia Care 27
May 15, 2017: Bioverativ Appoints Geno J. Germano to Companys Board of Directors 29
May 03, 2017: Bioverativ Reports First Quarter 2017 Results 30
Apr 10, 2017: Bioverativ Appoints Tim Harris Executive Vice President, Research and Development 32
Mar 02, 2017: Anna Protopapas to Join Bioverativ Board of Directors 33
Section 6 Appendix 34
Methodology 34
Ratio Definitions 34
About GlobalData 38
Contact Us 38
Disclaimer 38

List Of Tables


Bioverativ Inc, Key Facts 5
Bioverativ Inc, Key Employees 6
Bioverativ Inc, Key Employee Biographies 7
Bioverativ Inc, Major Products and Services 8
Bioverativ Inc, Other Locations 9
Bioverativ Inc, Subsidiaries 9
Bioverativ Inc, Key Competitors 15
Bioverativ Inc, Ratios based on current share price 16
Bioverativ Inc, Annual Ratios 17
Bioverativ Inc, Annual Ratios (Cont...1) 18
Bioverativ Inc, Interim Ratios 20
Bioverativ Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 22
Bioverativ Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 23
Bioverativ Inc, Recent Deals Summary 24
Currency Codes 34
Capital Market Ratios 34
Equity Ratios 35
Profitability Ratios 35
Cost Ratios 36
Liquidity Ratios 36
Leverage Ratios 37
Efficiency Ratios 37

List Of Figures


Bioverativ Inc, Performance Chart (2013 - 2016) 19
Bioverativ Inc, Ratio Charts 21
Bioverativ Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 22
Bioverativ Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 23

Bioverativ Inc (BIVV) - Financial and Strategic SWOT Analysis Review

Bioverativ Inc (BIVV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

USD 125View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
Country Code.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 125
  • Site Licence    USD 250
  • Enterprise Wide Licence    USD 375
$ 125

Reports Details

Published Date : Aug 2017
No. of Pages :38
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube
pendik escort tuzla escort antalya escort bayan kartal escort
instagram takipci hilesi
paykasa bozdurma,paykasa bozdurma,astropay bozdurma,paykasa,paykasa,paykasa bozdurma,paykasa,astropay bozdurma,justin kart,bitcoin bozdurma,paykasa bozum,paykasa kart bozdurma,
beylikduzu escort,bahçeşehir escort,escort istanbul,istanbul escort,sex hikayeleri,pendik escort,
pedalebiellese.com,
istanbul escort bayan,besiktas escort,maltepe escort,kadikoy escort bayan,tekirdag escort bayan,findikzade escort,antalya escort bayan,ankara escort bayan,
Böcek İlaçlama,şehirler arası nakliyat,şehirler arası evden eve nakliyat,ofis taşıma,gebze evden eve nakliyat,kadıköy evden eve nakliyat,istanbul evden eve nakliyat,epoksi zemin,
ankara escort,ankara escort,ankara escort,
tipobet,
seo teknikleri wordpress ücretsiz tema istanbul sexs shop hacklink e sigara sexs shop